On November 13, Ingram Micro Holding Corp. rose 5.79% in Regular Trading, trading at $29.6236/share, with turnover of $39.3404 million.
The clearest catalyst is the company’s upcoming addition to the S&P SmallCap 600, effective November 17, replacing Pacira BioSciences following the expected closing of Viatris’ acquisition of Pacira.
The index inclusion announcement was released on November 12 and was followed by a more than 5% move in after-hours trading, closely matching the current advance. As supporting context, Ingram Micro Holding Corp. recently reported Q3 non-GAAP EPS of $0.91 on revenue of $15.22 billion, both above consensus estimates, and guided Q4 non-GAAP EPS to $1.05-$1.15 on revenue of $17.50 billion-$17.90 billion, reinforcing a strong operating backdrop ahead of the index change.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments